Qianjiang Yongan Pharmaceutical Co Ltd Financial Flexibility Index
Qianjiang Yongan Pharmaceutical Co Ltd financial flexibility index. Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Financial Flexibility Index of 0.28x as of September 2025. Free cash flow of CN¥70.03 Million (operating CF CN¥58.18 Million minus capex CN¥11.85 Million) represents 0% of total liabilities (CN¥247.20 Million). See Qianjiang Yongan Pharmaceutical Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Financial flexibility index of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024. Historical Financial Flexibility Index trend for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. Check 002365 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Qianjiang Yongan Pharmaceutical Co Ltd Financial Flexibility Index by Year (2006–2024)
Qianjiang Yongan Pharmaceutical Co Ltd financial flexibility index by year from 2006 to 2024. Year-by-year free cash flow to debt coverage for Qianjiang Yongan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Qianjiang Yongan Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.84x | CN¥223.76 Million | CN¥105.71 Million | CN¥266.55 Million | ▼ -31.3% |
| 2023 | 1.22x | CN¥365.00 Million | CN¥244.26 Million | CN¥298.85 Million | ▼ -26.9% |
| 2022 | 1.67x | CN¥536.35 Million | CN¥387.28 Million | CN¥321.17 Million | ▲ +233.2% |
| 2021 | 0.50x | CN¥164.86 Million | CN¥101.81 Million | CN¥328.95 Million | ▼ -43.6% |
| 2020 | 0.89x | CN¥311.07 Million | CN¥206.66 Million | CN¥349.92 Million | ▼ -40.3% |
| 2019 | 1.49x | CN¥373.94 Million | CN¥239.55 Million | CN¥251.14 Million | ▼ -17.5% |
| 2018 | 1.81x | CN¥583.52 Million | CN¥314.02 Million | CN¥323.11 Million | ▼ -12.7% |
| 2017 | 2.07x | CN¥486.79 Million | CN¥197.32 Million | CN¥235.23 Million | ▲ +59.7% |
| 2016 | 1.30x | CN¥124.66 Million | CN¥84.53 Million | CN¥96.22 Million | ▲ +3.3% |
| 2015 | 1.25x | CN¥104.73 Million | CN¥70.61 Million | CN¥83.50 Million | ▲ +41.9% |
| 2014 | 0.88x | CN¥69.95 Million | CN¥19.26 Million | CN¥79.14 Million | ▼ -33.8% |
| 2013 | 1.34x | CN¥163.57 Million | CN¥63.65 Million | CN¥122.50 Million | ▼ -18.5% |
| 2012 | 1.64x | CN¥190.93 Million | CN¥70.75 Million | CN¥116.59 Million | ▼ -49.7% |
| 2011 | 3.26x | CN¥339.26 Million | CN¥91.23 Million | CN¥104.13 Million | ▲ +67.0% |
| 2010 | 1.95x | CN¥148.58 Million | CN¥44.06 Million | CN¥76.14 Million | ▲ +65.4% |
| 2009 | 1.18x | CN¥82.41 Million | CN¥36.43 Million | CN¥69.83 Million | ▼ -38.6% |
| 2008 | 1.92x | CN¥230.66 Million | CN¥158.47 Million | CN¥120.04 Million | ▼ -0.8% |
| 2007 | 1.94x | CN¥121.85 Million | CN¥61.08 Million | CN¥62.89 Million | ▲ +83.6% |
| 2006 | 1.06x | CN¥48.79 Million | CN¥31.11 Million | CN¥46.24 Million | — |